Hippocampal volume change in schizophrenia

Journal of Clinical Psychiatry

Volumn 71, Issue 6, 2010, Pages 737-744

  Koolschijn, P Cédric M P ^a   Van Haren, Neeltje E M ^a   Cahn, Wiepke ^a   Schnack, Hugo G ^a   Janssen, Joost ^b   Klumpers, Floris ^c   Pol, Hilleke E Hulshoff ^a   Kahn, René S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; SULPIRIDE;

ADULT; AGE; ARTICLE; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; ATROPHY; CHRONIC DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 77953784215     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04574yel     Document Type: Article

References (54)

1. Nelson MD, Saykin AJ, Flashman LA, et al. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 1998;55(5):433-440.
2. Wright IC, Rabe-Hesketh S, Woodruff PW, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157(1):16-25.
3. Boos HB, Aleman A, Cahn W, et al. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry. 2007;64(3):297-304. (Pubitemid 46376781)
4. Antonova E, Sharma T, Morris R, et al. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res. 2004;70(2-3):117-145. (Pubitemid 39141094)
5. Barch DM. The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol. 2005;1(1):321-353.
6. DeLisi LE, Sakuma M, Tew W, et al. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74(3):129-140. (Pubitemid 27315863)
7. Wood SJ, Velakoulis D, Smith DJ, et al. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr Res. 2001;52(1-2):37-46.
8. Whitworth AB, Kemmler G, Honeder M, et al. Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients. Psychiatry Res. 2005;140(3):225-237.
9. Chakos MH, Schobel SA, Gu H, et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br J Psychiatry. 2005;186(1):26-31. (Pubitemid 40070540)
10. Arango C, Breier A, McMahon R, et al. The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes. Am J Psychiatry. 2003;160(8):1421-1427. (Pubitemid 41070916)
11. McClure RK, Phillips I, Jazayerli R, et al. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment. Psychiatry Res. 2006;148(2-3):121-132.
12. Panenka WJ, Khorram B, Barr AM, et al. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophr Res. 2007;94(1-3):288-292. (Pubitemid 47031604)
13. van Haren NE, Hulshoff Pol HE, Schnack HG, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry. 2008;63(1):106-113.
14. Hulshoff Pol HE, Schnack HG, Mandl RCW, et al. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry. 2001;58(12):1118-1125.
15. van Haren NE, Hulshoff Pol HE, Schnack HG, et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology. 2007;32(10):2057-2066.
16. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49(8):615-623.
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. (Pubitemid 18039085)
18. Phelan M, Slade M, Thornicroft G, et al. The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry. 1995;167(5):589-595. (Pubitemid 26197767)
19. Hall RC. Global assessment of functioning: a modified scale. Psychosomatics. 1995;36(3):267-275.
20. Commissie Farmaceutische Hulp. Farmacotherapeutisch Kompas. Amstelveen, The Netherlands: Commissie Farmaceutische Hulp van het College voor Zorgverzekeringen; 2002.
21. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia. 2nd ed. Arlington, VA: American Psychiatric Association; 2004.
22. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV Personality, SIDP-IV. Iowa City, IA: Department of Psychiatry, University of Iowa; 1995.
23. Hulshoff Pol HE, Schnack HG, Bertens MG, et al. Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry. 2002;159(2):244-250. (Pubitemid 34126901)
24. Schnack HG, Hulshoff HE, Baaré WF, et al. Automatic segmentation of the ventricular system from MR images of the human brain. Neuroimage. 2001;14(1, pt 1):95-104. (Pubitemid 32564889)
25. Schnack HG, Baaré WF, Staal WG, et al. Automated separation of gray and white matter from MR images of the human brain. Neuroimage. 2001;13(1):230-237. (Pubitemid 34188260)
26. Baaré WF, van Oel CJ, Hulshoff Pol HE, et al. Volumes of brain structures in twins discordant for schizophrenia. Arch Gen Psychiatry. 2001;58(1):33-40.
27. Staal WG, Hulshoff Pol HE, Schnack HG, et al. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry. 2000;157(3):416-421. (Pubitemid 30145928)
28. Janssen J, Hulshoff Pol HE, Lampe IK, et al. Hippocampal changes and white matter lesions in early-onset depression. Biol Psychiatry. 2004;56(11):825-831.
29. Bartko JJ, Carpenter WT Jr. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163(5):307-317.
30. Cleveland WS, Devlin SJ. Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988;83(403):596-610.
31. Hastie T, Tibshirani R. Exploring the nature of covariate effects in the proportional hazards model. Biometrics. 1990;46(4):1005-1016.
32. Steen RG, Mull C, McClure R, et al. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry. 2006;188(6):510-518.
33. Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 2002;4(2):117-128.
34. Czéh B, Lucassen PJ. What causes the hippocampal volume decrease in depression? are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci. 2007;257(5):250-260.
35. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6(6):463-475.
36. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57(10):925-935.
37. Phillips LJ, McGorry PD, Garner B, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry. 2006;40(9):725-741.
38. Pantelis C, Velakoulis D, Wood SJ, et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry. 2007;19(4):371-379.
39. Häfner H, Maurer K, Trendler G, et al. Schizophrenia and depression: challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77(1):11-24.
40. Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004;161(4):598-607.
41. Videbech P, Ravnkilde B. Hippocampal volume and depression: a metaanalysis of MRI studies. Am J Psychiatry. 2004;161(11):1957-1966.
42. Kennedy KM, Erickson KI, Rodrigue KM, et al. Age-related differences in regional brain volumes: a comparison of optimized voxel-based morphometry to manual volumetry. Neurobiol Aging. 2009;30(10):1657-1676.
43. Walhovd KB, Fjell AM, Reinvang I, et al. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol Aging. 2005;26(9):1261-1270, discussion 1275-1278.
44. Lieberman JA, Tollefson GD, Charles C, et al, and the HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62(4):361-370.
45. Dazzan P, Morgan KD, Orr K, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30(4):765-774.
46. Wakade CG, Mahadik SP, Waller JL, et al. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res. 2002;69(1):72-79.
47. Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry. 2004;56(8):570-580.
48. Xu H, Chen Z, He J, et al. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus. 2006;16(6):551-559. (Pubitemid 43942103)
49. Schmitt A, Weber S, Jatzko A, et al. Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment. J Neural Transm. 2004;111(1):91-100. (Pubitemid 38177820)
50. Xu H, Qing H, Lu W, et al. Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett. 2002;321(1-2):65-68. (Pubitemid 34185500)
51. Park SW, Lee SK, Kim JM, et al. Effects of quetiapine on the brainderived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci Lett. 2006;402(1-2):25-29.
52. Parikh V, Khan MM, Mahadik SP. Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neurosci Lett. 2004;356(2):135-139. (Pubitemid 38121487)
53. Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 1994;263(5153):1618- 1623. (Pubitemid 24128367)
54. Angelucci F, Brenè S, Mathé AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10(4):345-352. (Pubitemid 40490802)